Animal health product developer Bactana is advancing Cornell University research into probiotics that could lead to improved vitality for livestock including cattle, swine and poultry.
Bactana, a US-based animal health product developer that has licensed Cornell University research, has closed a $1.3m equity round featuring Cornell and Connecticut Innovations, the venture capital vehicle for the State of Connecticut. VC fund Sustainable Income Capital Management also took part in the round, as did unnamed additional funds and private investors. The deal…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
